Utama › Kanser Pankreas › Virginia › Arlington
Kajian klinikal Kanser Pankreas di Arlington, VA
33 kajian untuk Kanser Pankreas sedang mencari peserta di lokasi dalam dan sekitar Arlington (dalam lingkungan kira-kira 30 batu). Buka kajian untuk melihat siapa yang layak menyertai dan cara menghubungi pasukan kajian.
Teks kajian rasmi (Bahasa Inggeris)
Mengambil peserta untuk kajian di sini? Paparkan di bahagian atas halaman ini — $99 selama 30 hari →
The Vanguard Study: Testing a New Way to Screen for Cancer
Mengambil pesertaSukarelawan sihat dialu-alukan
- Inova Schar Cancer Institute, Fairfax · 11 mi jauh
- Inova Fair Oaks Hospital, Fairfax · 11 mi jauh
Atebimetinib + GnP as a First Line Treatment in Patients With Metastatic Pancreatic Adenocarcinoma
Mengambil pesertaFasa 3
- Virginia Cancer Specialists, Fairfax · 11 mi jauh
Phase 1/2 Study of BHB810 in Advanced Gastric and GEJ Adenocarcinoma
Mengambil pesertaFasa 1/2
- NEXT Virginia, Fairfax · 11 mi jauh
A Study of PHN-012 in Patients With Advanced Solid Tumors
Mengambil pesertaFasa 1
- PHN-012-001 Site, Fairfax · 11 mi jauh
A Study of IDE892 as Monotherapy and Combination in MTAP-deleted Advanced Solid Tumors
Mengambil pesertaFasa 1
- NEXT Oncology Virginia, Fairfax · 11 mi jauh
Study of Daraxonrasib (RMC-6236) in Patients With Resected Pancreatic Ductal Adenocarcinoma (PDAC)
Mengambil pesertaFasa 3
- Virginia Cancer Specialists, Fairfax · 11 mi jauh
A Study to Evaluate Chemotherapy With or Without INCB161734 in Previously Untreated, KRAS G12D-Mutated Metastatic Pancreatic Ductal Adenocarcinoma
Mengambil pesertaFasa 3
- Investigative Site US057, Fairfax · 11 mi jauh
- Investigative Site US065, Fairfax · 11 mi jauh
A Study to Evaluate the Effectiveness and Safety of Setidegrasib, Given With Either mFOLFIRINOX or NALIRIFOX Chemotherapies, in People With Pancreatic Cancer
Mengambil pesertaFasa 3
- Inova Schar Cancer Institute Clinical Trials, Fairfax · 11 mi jauh
Study of RAS(ON) Inhibitors in Patients With Gastrointestinal Solid Tumors
Mengambil pesertaFasa 1/2
- Virginia Cancer Specialists, Fairfax · 11 mi jauh
Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors
Mengambil pesertaFasa 1/2
- NEXT Oncology Virginia, Fairfax · 11 mi jauh
A First-in-Human Trial of BLU-924 (SAR449336) in Advanced Solid Tumors Harboring KRAS Mutations
Mengambil pesertaFasa 1/2
- Next Oncology Virginia Cancer Specialist, Fairfax · 11 mi jauh
Study of RMC-5127 in Patients With Advanced KRAS G12V-Mutant Solid Tumors
Mengambil pesertaFasa 1
- NEXT - Virginia, Fairfax · 11 mi jauh
A Study to Evaluate Safety, Tolerability and Preliminary Activity of AGX101 in Participants With Advanced Solid Tumors
Mengambil pesertaFasa 1
- NEXT Oncology, Fairfax · 11 mi jauh
Comparing the Clinical Impact of Pancreatic Cyst Surveillance Programs and Associated Biomarkers
Mengambil pesertaKajian pemerhatian
- Inova Fairfax Hospital, Falls Church · 4 mi jauh
- Inova Schar Cancer Institute, Fairfax · 11 mi jauh
- Inova Fair Oaks Hospital, Fairfax · 11 mi jauh
A Phase 2 Study of VS-7375 in Patients With KRAS G12D-Mutated Pancreatic Cancer
Mengambil pesertaFasa 2
- Virginia Cancer Specialists, Fairfax · 11 mi jauh
Phase 1 Study of MRTX1719 in Solid Tumors With MTAP Deletion
Mengambil pesertaFasa 1
- Virginia Cancer Specialists, PC, Fairfax · 11 mi jauh
Testing Higher Dose Radiation Therapy for Locally Advanced Pancreatic Cancer
Mengambil pesertaFasa 3
- Inova Fairfax Hospital, Falls Church · 4 mi jauh
- Inova Schar Cancer Institute, Fairfax · 11 mi jauh
- Inova Fair Oaks Hospital, Fairfax · 11 mi jauh
A Study of MRG007 (ARR-217) in Patients With Advanced Solid Tumors
Mengambil pesertaFasa 1
- NEXT Virginia, Fairfax · 11 mi jauh
Pancreatic Cancer Early Detection Consortium
Mengambil pesertaKajian pemerhatianSukarelawan sihat dialu-alukan
- Inova Schar Cancer Institute, Fairfax · 11 mi jauh
A Study of PT0511 in Participants With KRAS Mutated or Amplified Advanced Solid Tumors
Mengambil pesertaFasa 1
- NEXT Virginia, Fairfax · 11 mi jauh
A Phase 1 Dose-escalation Trial of KST-6051 in Participants With Advanced Solid Tumors With Kirsten Rat Sarcoma Viral Oncogene Homolog (KRAS) Mutation
Mengambil pesertaFasa 1
- NEXT Virginia, Fairfax · 11 mi jauh
Study to Assess Adverse Events and Pharmacokinetics in Adult Participants With Non-Small Cell Lung Cancer, Head and Neck Squamous Cell Carcinoma and Other Solid Tumors, Receiving Intravenous Infusion of Azirkitug Alone or in Combination(s) With Budigalimab, Bevacizumab, or Telisotuzumab Adizutecan
Mengambil pesertaFasa 1
- Virginia Cancer Specialists - Fairfax /ID# 232592, Fairfax · 11 mi jauh
A Study to Learn About Study Medicine ALTA3263 in Adults With Advanced Solid Tumors With KRAS Mutations
Mengambil pesertaFasa 1
- Research Site, Fairfax · 11 mi jauh
Study of RMC-9805 in Participants With KRAS G12D-Mutant Solid Tumors
Mengambil pesertaFasa 1
- NEXT Oncology Virginia, Fairfax · 11 mi jauh
A Study to Evaluate the Safety, Tolerability, and Efficacy of BMS-986523 Alone and in Combination With Anti-Cancer Agents in Participants With Advanced Solid Malignancies
Mengambil pesertaFasa 1/2
- NEXT Virginia, Fairfax · 11 mi jauh
Studying Chemotherapy With or Without Panitumumab for Unresectable, Locally Advanced, or Metastatic Pancreatic Cancer Without KRAS Mutations
Mengambil pesertaFasa 3
- Inova Schar Cancer Institute, Fairfax · 11 mi jauh
- Inova Fair Oaks Hospital, Fairfax · 11 mi jauh
Study of RMC-6236 in Patients With Advanced Solid Tumors Harboring Specific Mutations in RAS
Mengambil pesertaFasa 1/2
- Next Oncology Virginia, Fairfax · 11 mi jauh
A 2-part Phase 1/2 Open-label Trial on ODM-212
Mengambil pesertaFasa 1/2
- NEXT Oncology Virginia, Fairfax · 11 mi jauh
A Study of TSN1611 Treating Patients With Advanced Solid Tumors Harboring KRAS G12D Mutation
Mengambil pesertaFasa 1/2
- NEXT Virginia, Fairfax · 11 mi jauh
A Phase 1/2 Study of VS-7375 in Patients With KRAS G12D-Mutated Solid Tumors
Mengambil pesertaFasa 1/2
- Virginia Cancer Specialists, Fairfax · 11 mi jauh
A Study Evaluating FMC-376 in Participants With KRAS G12C Mutated Solid Tumors
Mengambil pesertaFasa 1/2
- Virginia Cancer Specialists, Fairfax · 11 mi jauh
Study of CP-383 in Patients With Advanced or Metastatic Solid Tumors
Mengambil pesertaFasa 1/2
- NEXT Virginia, Fairfax · 11 mi jauh
Phase 1/2 Dose Finding, Safety and PK Study in Advanced Refractory Solid Tumors
Mengambil pesertaFasa 1/2
- NEXT, Virginia, Fairfax · 11 mi jauh
Kajian Kanser Pankreas di bandar lain
- Houston, TX61 kajian
- New York City, NY60 kajian
- Boston, MA43 kajian
- Nashville, TN39 kajian
- Los Angeles, CA35 kajian
- St. Louis, MO33 kajian
- Baltimore, MD31 kajian
- San Antonio, TX31 kajian
- Philadelphia, PA26 kajian
- Tampa, FL26 kajian
- Durham, NC24 kajian
- San Diego, CA24 kajian
Kajian lain di Arlington
- Kanser Paru-paru Bukan Sel Kecil104 kajian
- Kanser Metastatik53 kajian
- Kanser Kolorektal52 kajian
- Kanser (semua jenis)48 kajian
- Kanser Payudara47 kajian
- Kanser Ovari46 kajian
- Kanser Paru-paru41 kajian
- Kanser Endometrium39 kajian
- Karsinoma Sel Skuamosa Kepala dan Leher26 kajian
- Kanser Paru-paru Sel Kecil23 kajian
- Kanser Perut20 kajian
- Kanser Payudara Triple-Negatif20 kajian
Daripada ClinicalTrials.gov, data diperoleh pada 6 Okt 2026. Setiap kajian menetapkan kriteria kelayakannya sendiri; pasukan kajian menentukan siapa yang layak menyertai.